AI Verdict
ENSCW has stronger fundamentals based on our AI analysis.
ENTA vs ENSCW Fundamental Comparison
| Metric | ENTA | ENSCW |
|---|---|---|
| Revenue | $18.6M | $3.2M |
| Net Income | $-11.9M | $-7.4M |
| Net Margin | -64.1% | -232.6% |
| ROE | -9.4% | -615.6% |
| ROA | -3.6% | -233.0% |
| Current Ratio | 4.44x | 1.27x |
| Debt/Equity | 0.02x | 0.00x |
| EPS | $-0.42 | $-3.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ENTA vs ENSCW: Frequently Asked Questions
Is ENTA or ENSCW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ENSCW has stronger fundamentals. ENTA is rated STRONG SELL (85% confidence) while ENSCW is rated STRONG SELL (95% confidence). This is not investment advice.
How does ENTA compare to ENSCW fundamentally?
ENANTA PHARMACEUTICALS INC has ROE of -9.4% vs Ensysce Biosciences, Inc.'s -615.6%. Net margins are -64.1% vs -232.6% respectively.
Which stock pays higher dividends, ENTA or ENSCW?
ENTA has a dividend yield of N/A or no dividend while ENSCW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ENTA or ENSCW for long term?
For long-term investing, consider that ENTA has STRONG SELL rating with 85% confidence, while ENSCW has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ENTA vs ENSCW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ENTA vs ENSCW, the AI consensus favors ENSCW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.